Crossbow Therapeutics has successfully hit a $77 million series B round, which the biotech will use to fund a trial of its lead T-cell engager (TCE) and fill its quiver with more T-Bolts.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
Resonate Group, an ambitious Nigerian indigenous company with global aspirations, that aligns her vision with strategic intent to provide innovative solutions and services in Oil & Gas, Maritime, Manufacturing, Finance, Steel, Healthcare, and Supply Chain sectors of the Nigerian economy...
Recent Post
Copyright 2024 - All Rights Reserved By Resonate Group | Designed By Nysut Digital Studios